Platinum-catalysed intravaginal rings

Karl Malcolm (Inventor), David Woolfson (Inventor), Joseph Romano (Inventor)

Research output: Patent

47 Downloads (Pure)

Abstract

The present invention provides improved intravaginal drug delivery devices, i.e., intravaginal rings, useful for the prophylactic administration of an antimicrobial compound, e.g., Dapivirine, to a human. The intravaginal rings of the invention address previous stability issues by utilizing a platinum catalyst (e.g., in the form of a platinum-siloxane complex) for the cross-linking reaction. The vaginal rings surprisingly achieve relatively high and steady release rates in vivo with a matrix ring containing a relatively small loading dose. While the matrix rings of the present invention have in vivo the steady release rates associated with reservoir rings, they are easier and less expensive to manufacture. The present invention also provides methods of blocking DNA polymerization by an HIV reverse transcriptase enzyme, methods of preventing HIV infection in a female human, methods of treating HIV infection in a female human, and methods of preparing platinum-catalyzed intravaginal rings.
Original languageEnglish
Patent number20120093911
Publication statusPublished - 19 Apr 2012

Fingerprint Dive into the research topics of 'Platinum-catalysed intravaginal rings'. Together they form a unique fingerprint.

  • Cite this

    Malcolm, K., Woolfson, D., & Romano, J. (2012). Platinum-catalysed intravaginal rings. (Patent No. 20120093911).